Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE)

Cash, Hannes; Steiner, Ursula; Heidenreich, Axel; Klotz, Theodor; Albers, Peter; Melchior, Sebastian; Martus, Peter; Fuller, Florian; Magheli, Ahmed; Hinz, Stefan; Kempkensteffen, Carsten; Miller, Kurt

dc.contributor.author	Martus, Peter
dc.date.accessioned	2019-07-16T08:50:21Z
dc.date.available	2019-07-16T08:50:21Z
dc.date.issued	2018
dc.identifier.issn	1464-410X
dc.identifier.uri	http://hdl.handle.net/10900/90593
dc.language.iso	en	de_DE
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/bju.14239	de_DE
dc.subject.ddc	610	de_DE
dc.title	Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00651
utue.publikation.seiten	774-782	de_DE
utue.personen.roh	Cash, Hannes
utue.personen.roh	Steiner, Ursula
utue.personen.roh	Heidenreich, Axel
utue.personen.roh	Klotz, Theodor
utue.personen.roh	Albers, Peter
utue.personen.roh	Melchior, Sebastian
utue.personen.roh	Martus, Peter
utue.personen.roh	Fuller, Florian
utue.personen.roh	Magheli, Ahmed
utue.personen.roh	Hinz, Stefan
utue.personen.roh	Kempkensteffen, Carsten
utue.personen.roh	Miller, Kurt
dcterms.isPartOf.ZSTitelID	Bju International	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	122	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE